Coronado Biosciences announced the appointment of Harlan F. Weisman, M.D., a director for the company since August 2012, as its new chairman and CEO. Dr. Weisman was most recently at Johnson and Johnson, where he held a number of leadership positions, and before that he was the head of R&D at Centocor, the developer of Remicade, which was acquired by JNJ.
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Futures fell on reports of Iran explosions: The market power trend is about to end. Netflix gave weak guidance.
(Bloomberg) -- Markets remained on edge on Friday after an escalation of the tensions in the Middle East sent stocks tumbling around the world and stoked demand for haven assets including bonds and the dollar.Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityIsrael Launches Retaliatory Strike on Iran, US Officials SayRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingThese Are the World’s Best Airports in 2024Gains for Treasuries drove
This is what could happen next to Palantir shares.
Berkshire Hathaway is one of the biggest bets within the Bill & Melinda Gates Foundation Trust portfolio.
The adoption of AI is just getting started, offering astute investors the opportunity to profit from this step change in technology.
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
You don't have to be a stock market genius to outperform most pros.
Netflix reported first quarter earnings after the bell on Thursday. Here's what to know.
The insurer was accused by a short-seller of "extensive" fraud.
